QNRX Stock Summary and Trading Ideas (Quoin Pharmaceuticals Ltd. - American Depositary Shares | NASDAQ:QNRX)

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Quoin Pharmaceuticals Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol QNRX.

As of February 13, 2026, QNRX stock price climbed to $8.40 with 3,611 million shares trading.

QNRX has a beta of -1.01, meaning it tends to be less sensitive to market movements. QNRX has a correlation of 0.01 to the broad based SPY ETF.

QNRX has a market cap of $13.58 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, QNRX traded as high as $671.96 and as low as $5.01.

QNRX has underperformed the market in the last year with a return of -27.5%, while the SPY ETF gained +13.0%. In the last 3 month period, QNRX fell short of the market, returning -37.4%, while SPY returned +1.7%. However, in the most recent 2 weeks QNRX has outperformed the stock market by returning +16.4%, while SPY returned -1.5%.

QNRX support price is $7.63 and resistance is $8.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QNRX shares will trade within this expected range on the day.